Neocal    500 Tablet Bangladéš - angličtina - DGDA (Directorate General of Drug Administration)

neocal 500 tablet

the white horse pharmaceuticals ltd. - calcium carbonate - tablet - 1250 mg

TSE Neonatal Phototherapy Unit LiLLY Singapur - angličtina - HSA (Health Sciences Authority)

tse neonatal phototherapy unit lilly

its science & medical pte ltd - general hospital - neonatal phototherapy unit is intended for treatment for neonatal hyperbilirubinaemia (emission of intensive light radiation within the spectrum of 400 – 550nm reduces bilirubin concentration in newborn’s body). radiation of the phototherapy unit in blue spectrum modifies dangerous bilirubi to a non-toxic form, which is more easily excreted from newborn’s body.

BD  Tanzánia - angličtina - Tanzania Medicinces & Medical Devices Authority

bd

becton dickinson east africa limited, kenya - neonatal spinal needle -

NEONATAL MAINTENANCE SOLUTION WITH DEXTROSE 5% INFUSION (PARENTERAL) Južná Afrika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

neonatal maintenance solution with dextrose 5% infusion (parenteral)

bodene (pty) ltd trading as intramed - infusion (parenteral) - see ingredients - each 1 000 ml solution contains anhydrous sodium phosphate 0,2662 g calcium chloride 0,5475 g dextrose, anhydrous 50 g magnesium chloride 0,25375 g monobasic sodium phosphate (anhydrous) 0,450 g potassium chloride a

Enteroporc Coli AC Európska únia - angličtina - EMA (European Medicines Agency)

enteroporc coli ac

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - pigs - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin

Hevea-latex examination/treatment glove, non-powdered Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

hevea-latex examination/treatment glove, non-powdered

nekvapil pty ltd - 47172 - hevea-latex examination/treatment glove, non-powdered - a glove made of hevea natural rubber latex (nrl) intended as a protective barrier when worn on the hands of healthcare providers during patient examination/treatment or for other sanitary purposes. the device is used mainly as a two-way barrier to protect both the patient and the staff against various contamination.

Nitrile examination/treatment glove, non-powdered Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

nitrile examination/treatment glove, non-powdered

nekvapil pty ltd - 56286 - nitrile examination/treatment glove, non-powdered - a non-sterile device made of nitrile intended as a protective barrier when worn on the hands of healthcare providers duringpatient examination/treatment or for other sanitary purposes; its inner surface is not covered with talcum powder. thedevice is used mainly as a two-way barrier to protect patient/staff against contaminants and risk of allergy to latex. it willhave appropriate characteristics regarding tactility and comfort of use, and should provide appropriate physical properties(e.g., tensile strength, resistance to puncture, elasticity), and uniformity of dimensions (i.e., sizing consistency). this is asingle-use device.

NARCAN NEONATAL Írsko - angličtina - HPRA (Health Products Regulatory Authority)

narcan neonatal

bristol-myers squibb pharmaceuticals ltd - naloxone hydrochloride - solution for injection - 20/1 microgram/ml